Selinexor combination with decitabine and half-dose CMG (Cytarabine+ Mitoxantrone+G-CSF) in Patients with refractory/relapsed acute myeloid leukemia (AML) previously exposed to Venetoclax: a single-center retrospective study - Zi-Yu Zhao; Xiao-Lei Zhang; Ying Zhan; Ya-Bei Zuo; Jin-Ao Li; Jin-Hai Ren; Xiao-Ling Guo; Zi-Yuan Nie (Leukemia Research Reports)